Cambridge, Mass.-based drugmaker Biogen struck a more than $1 billion deal with South San Francisco-based biotech company Denali Aug. 6 to co-develop and co-commercialize small molecule inhibitors to treat Parkinson's disease.
Pharmacy
Researchers developing a COVID-19 vaccine are struggling to enroll minorities in clinical trials to test the experimental vaccines, The Wall Street Journal reported.
The American Society of Health-Systems Pharmacists named 18 of its members to a task force on racial diversity, equity and inclusion Aug. 6.
Since the FDA said in May that it found unacceptable levels of a carcinogen in metformin, a popular diabetes drug, 10 companies have recalled their metformin products.
The National Institutes of Health will begin a wide-ranging series of studies on potential COVID-19 drugs called monoclonal antibodies, synthetic versions of proteins produced by people who have recovered from the virus, it said this week.
Advertisement
Good Neighbor Pharmacy was the highest-ranked pharmacy in the U.S. for the second year in a row in terms of customer satisfaction, according to consumer insight firm J.D. Power's annual pharmacy satisfaction survey.
President Donald Trump signed an executive order Aug. 6 directing the government to buy certain drugs only from American factories.
Moderna plans to charge $32 to $37 per dose for customers buying small orders of its COVID-19 vaccine, according to a transcript of an Aug. 5 Q2 earnings call by The Motley Fool.
Mallinckrodt is considering filing for Chapter 11 bankruptcy protection to address its opioid related liabilities and corporate debts, The Wall Street Journal reported.
Throughout the pandemic, the malaria drug hydroxychloroquine has made frequent appearances in national headlines as the medical community works to establish a cohesive opinion on the drug's effectiveness in treating COVID-19.